Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
32 studies found for:    " May 05, 2010":" June 04, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" May 05, 2010":" June 04, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed DCVax Plus Poly ICLC in Healthy Volunteers
Conditions: HIV-1 Infection;   HIV Infection;   Healthy Volunteers
Interventions: Drug: DCVax-001;   Drug: Poly-ICLC;   Drug: Placebo
2 Completed Intervention Targeting Medication Adherence and Methamphetamine Use in HIV Positive Men (ACE)
Conditions: HIV Medication Adherence;   Methamphetamine Use;   Sexual Risk;   Poly-substance Use;   HIV Infections
Interventions: Behavioral: Motivational Interviewing + Cognitive Behavioral Skills Training;   Behavioral: Education Attention Control
3 Unknown  Evaluation of a Computer-Based System Using Cell Phones for HIV People in Peru
Conditions: HIV;   Adherence;   Sexual Behavior;   HIV Infections
Intervention: Other: Cell phone intervention
4 Recruiting Computerized Brief Alcohol Intervention (BI) for Binge Drinking HIV At-Risk and Infected Women
Conditions: Hazardous Alcohol Use;   Binge Drinking;   High Risk Sexual Behaviors;   HIV Risk Reduction;   HIV Infection
Interventions: Behavioral: Computerized brief alcohol intervention with IVR booster calls;   Behavioral: Computer delivered brief alcohol intervention;   Behavioral: Attention Control
5 Terminated A Safety and Immunogenicity Study of 3 Doses of Opal Immunotherapy in HIV Infected People
Condition: HIV Infections
Interventions: Biological: Opal-HIV-Gag(c) Low Dose;   Biological: Opal-HIV-Gag(c) Medium dose;   Biological: Opal-HIV-Gag(c) High dose;   Other: Dimethyl Sulfoxide
6 Completed Cardiovascular Diseases in HIV-infected Subjects (HIV-HEART Study)
Conditions: Detection of Frequency, Severity and Progression of Cardiovascular Diseases in Patients With HIV-infection.;   Effect on Cardiovascular Risk and Life Quality by Age, Gender, Classic Cardiovascular Risk Factors,;   HIV-specific Cardiovascular Risk Factors, Cardiovascular Medication, Antiretroviral Medication
Intervention:
7 Unknown  Tenofovir Renal Toxicity and Glomerular Filtration Rate (GFR) Validation
Conditions: Renal Function;   HIV Infection
Intervention: Other: Tc99mDTPA renal clearance
8 Active, not recruiting Evaluation of Simplified Antiretroviral Treatment Strategies in HIV Infected Children Treated by Antiretroviral (ARV) Before One Year of Age
Condition: HIV Infections
Interventions: Drug: AZT-3TC-LPV/r twice a day;   Drug: ABC-3TC-EFV once a day
9 Completed Reducing Health Problems Associated With Injection Drug Use
Conditions: Intravenous Drug Abuse;   HIV Infections
Interventions: Behavioral: Skin and Needle Hygiene Intervention;   Other: No intervention - assessment-only condition
10 Unknown  Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: LPV/r
11 Completed Venue-Based Couples CoOp in South Africa
Conditions: Alcoholism;   HIV Infections
Interventions: Behavioral: Couples Intervention;   Behavioral: Women's CoOp;   Behavioral: Women's CoOp and Men's Intervention
12 Completed Stonewall Treatment Evaluation Project
Conditions: Substance Abuse;   HIV Infections
Intervention: Behavioral: Stonewall Project
13 Completed The Immunogenicity of Varicella-zoster Virus Vaccine in HIV-infected Children
Conditions: HIV Infections;   Varicella-Zoster Virus
Intervention: Biological: VZV vaccination
14 Active, not recruiting Low Dose Atazanavir/r Versus Standard Dose Atazanavir/r (LASA)
Condition: HIV Infections
Intervention: Drug: ATV/r
15 Terminated The First Failure Study
Conditions: HIV;   HIV Infections
Interventions: Drug: Darunavir, Ritonavir, Truvada;   Drug: Darunavir, Ritonavir and Etravirine
16 Active, not recruiting Brief Intervention for Drug Misuse in the Emergency Department
Conditions: Substance Abuse Detection;   HIV;   Hepatitis B;   Hepatitis C;   Brief Intervention;   HIV Infections
Intervention: Behavioral: Brief motivational intervention
17 Terminated Novel Interventions in HIV-1 Infection
Condition: HIV-1 Infection
Interventions: Biological: GTU-MultiHIV B clade vaccine1mg;   Drug: Interleukin-2;   Drug: GM-CSF;   Drug: Growth Hormone
18 Completed A Drug Interaction Study Between Simvastatin, Atorvastatin, Rosuvastatin, and GSK2248761 in Healthy Subjects.
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK2248761;   Drug: Simvastatin;   Drug: Atorvastatin;   Drug: Rosuvastatin
19 Active, not recruiting Effectiveness of Zidovudine vs. Zidovudine Plus Alpha Interferon vs. Interferon for Treatment of HIV
Condition: HIV Infection
Intervention: Drug: Ziodovudine and Alpha Interferon
20 Recruiting Selective Exposure in HIV Prevention
Condition: HIV Infections
Interventions: Other: Instrumental meta intervention;   Other: Empowering meta-intervention;   Other: Control

   Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results    Last Page
Indicates status has not been verified in more than two years